Characteristic cardiovascular manifestation in homozygous and heterozygous familial hypercholesterolemia

被引:57
|
作者
Kawaguchi, A
Miyatake, K
Yutani, C
Beppu, S
Tsushima, M
Yamamura, T
Yamamoto, A
机构
[1] Natl Cardiovasc Ctr, Res Inst, Dept Etiol & Pathophysiol, Suita, Osaka 565, Japan
[2] Natl Cardiovasc Ctr, Res Inst & Hosp, Dept Etiol & Pathophysiol, Suita, Osaka 565, Japan
关键词
D O I
10.1016/S0002-8703(99)70485-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The aortic valve dysfunction of patients with homozygous familial hypercholesterolemia (FH) suggests that hypercholesterolemia affects not only coronary arteries but also the aortic valve. We studied the aortic root of patients with homozygous FH and those of patients with heterozygous FH to characterize the premature atherosclerotic lesions by using histopathologic specimens, Methods and Results The aortic roots of 10 patients with homozygous FH, age 9 to 58 years, were studied by cardiac catheterization with several angiographies. The aortic roofs of 39 patients with heterozygous FH under age 60 years were also examined For aortic and mitral valvular functions by color Doppler echocardiography, and 30 normocholesterolemic patients with coronary artery disease were examined as control subjects. In addition, in 22 patients with FH and 20 control subjects, the internal diameter of the aortic annulus and the aortic ridge in cardiac cycles were measured. Of the 10 homozygotes with FH, 8 patients had aortic regurgitation demonstrated by aortography; 3 ct them showed significant transvalvular pressure gradients. Stenotic changes of coronary ostia were observed in 8 of the 10 homozygotes with moderate coronary atherosclerosis. Of the 39 heterozygotes with FH, 10 patients had aortic regurgitation shown by Doppler echocardiography, as did only 1 of the 30 control subjects (P < .05). The average diameter and distensibility of the ascending aorta were significantly reduced in the heterozygotes compared with the control subjects, The surgically resected cusp specimens of aortic valves obtained from 1 homozygous and 1 heterozygous patient showed significant thickening of the cusp with foam cell infiltration. Conclusions :Premature atherosclerosis in FH had a characteristic distribution, affecting the aortic root dominantly. The involvement of the aortic valve indicating "hypercholesterolemic valvulopathy" was a peculiar feature of FH, especially ifs homozygous form, but was reminiscent of ubiquitous processes caused by hypercholesterolemia.
引用
收藏
页码:410 / 418
页数:9
相关论文
共 50 条
  • [1] Genetic screening for homozygous and heterozygous familial hypercholesterolemia
    Izar, Maria C.
    Machado, Valeria A.
    Fonseca, Francisco A.
    [J]. APPLICATION OF CLINICAL GENETICS, 2010, 3 : 147 - 157
  • [2] Emerging Treatments for Heterozygous and Homozygous Familial Hypercholesterolemia
    Baum, Seth J.
    Soifer, Daniel
    Duell, P. Barton
    [J]. REVIEWS IN CARDIOVASCULAR MEDICINE, 2016, 17 (1-2) : 17 - 25
  • [3] CARDIOVASCULAR ABNORMALITY IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    MITCHELL, AG
    RAPHAEL, MJ
    THOMPSON, GR
    OAKLEY, CM
    [J]. BRITISH HEART JOURNAL, 1977, 39 (03): : 342 - 342
  • [4] CARDIOVASCULAR COMPLICATIONS OF HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    ALLEN, JM
    THOMPSON, GR
    MYANT, NB
    STEINER, R
    OAKLEY, CM
    [J]. BRITISH HEART JOURNAL, 1980, 44 (04): : 361 - 368
  • [5] Alirocumab efficacy in patients with double heterozygous, compound heterozygous, or homozygous familial hypercholesterolemia
    Hartgers, Merel L.
    Defesche, Joep C.
    Langslet, Gisle
    Hopkins, Paul N.
    Kastelein, John J. P.
    Baccara-Dinet, Marie T.
    Seiz, Werner
    Hamon, Sara
    Banerjee, Poulabi
    Stefanutti, Claudia
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2018, 12 (02) : 390 - 396
  • [6] Spectrum of cardiovascular manifestations in homozygous familial hypercholesterolemia
    Bajaj, Nitin
    Singh, Balbir
    Ramamoorthy, Ananthkrishnan
    Ghosh, Arijit Kumar
    [J]. JOURNAL OF MARINE MEDICAL SOCIETY, 2023, 25 (01) : 88 - 92
  • [7] CARDIOVASCULAR DISEASE IN CHILDREN WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Lischka, J.
    Baumgartner, M.
    De Gier, C.
    Willfort-Ehringer, A.
    Greber-Platzer, S.
    [J]. ATHEROSCLEROSIS, 2022, 355 : E229 - E229
  • [8] Evinacumab and Cardiovascular Outcome in Patients With Homozygous Familial Hypercholesterolemia
    Beliard, Sophie
    Saheb, Samir
    Litzler-Renault, Stephanie
    Vimont, Alexandre
    Valero, Rene
    Bruckert, Eric
    Farnier, Michel
    Gallo, Antonio
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2024, 44 (06) : 1447 - 1454
  • [9] HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA - CARDIOVASCULAR FINDINGS IN 2 PATIENTS
    KELLER, C
    LOHMOLLER, G
    SCHMITZ, H
    [J]. MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1980, 122 (48): : 1717 - 1720
  • [10] CARDIOVASCULAR FEATURES OF HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN 8 PATIENTS
    PISCIONE, F
    CAPPELLIBIGAZZI, M
    POSTIGLIONE, A
    GNASSO, A
    FOCACCIO, A
    CHIARIELLO, M
    [J]. ARTERIOSCLEROSIS, 1987, 7 (05): : A515 - A515